Clinical Trials Directory

Trials / Unknown

UnknownNCT00283738

MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant

A Prospective, Multi-Center, Double-Blinded, Placebo-Controlled Trial to Evaluate the Effectiveness of Patent Foramen Ovale Closure With the BioSTAR Septal Repair Implant to Reduce Refractory Migraine Headache With Aura.

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
610 (estimated)
Sponsor
NMT Medical · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to investigate the safety and effectiveness of PFO closure with the BioSTAR Septal Repair Implant System in a population of patients that have refractory migraine (with aura) and who have failed medications.

Detailed description

During the last five years, transcatheter and surgical closure of PFO in the cyrptogenic stroke and TIA population has grown in frequency world-wide. Observational retrospective reports, from both single and multi-center experiences of over 400 patients, suggest Patent Foramen Ovale (PFO) closure to reduce the risk of recurrent migraine events in these populations may be beneficial, particularly for those patients in the migraine with aura subgroup. Although none of these reports are from prospective, randomized, controlled trials, the reports are compelling enough in their totality to support further investigation of a well defined group in a prospective manner. The patients reported in these studies were brought to PFO closure with no expectation of their procedure having any impact on their migraine. In fact, in many cases, the discovery of a history of migraine was not made until well after the PFO closure procedure. This clinical trial will prospectively compare the safety and effectiveness of PFO closure with the BioSTAR device to a control arm. Patients will be followed one year post-implant.

Conditions

Interventions

TypeNameDescription
DEVICEBioSTAR Septal Repair Implant SystemPFO Closure
PROCEDURESham ProcedureCatheterization

Timeline

Start date
2006-02-01
Completion
2008-03-01
First posted
2006-01-30
Last updated
2008-01-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00283738. Inclusion in this directory is not an endorsement.